Saudi Arabia / Significant Steps Towards Clinical Trial Hub Status
Clinical trials provide a pathway to innovation for clinicians and patients in countries like Saudi Arabia and form…
Middle East & Africa
Turkey / Pharma Industry Data Snapshot 2021
According to a recent report by IEIS, Turkey’s Pharmaceutical Manufacturers Association, there are approximately…
MEA / Georg Schroeckenfuchs of Novartis: ‘Shooting for the Moon’ in Saudi
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA)…
Data / Top 10 Pharma Companies in Saudi Arabia 2019
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10…
Turkey / A Moment of Reckoning on Diabetes?
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took…
Pharma Faces / Dimitri Livadas, Lilly Saudi Arabia
Having commenced his journey with American giant Lilly in 2008, and after almost eight years working in the…
In Conversation
Fayad Al Dandashi – CEO, Tamer HealthCare
Dr Fayad Al Dandashi, CEO of Tamer HealthCare, a leading Saudi healthcare company, discusses how the group aims to benefit from Saudi Arabia’s healthcare transformation through digitalization, changing their product-oriented…
Güldem Berkman – General Manager Turkey, Amgen…
Amgen, the American biotech giant, established a direct presence in Turkey in 2010 by acquiring a local generics manufacturer for US 700 million. Its general manager in the country, Güldem…
Frederico Silva – General Manager, Gilead Sciences…
Frederico Silva outlines the highlights of his two years heading up Gilead Sciences’ relatively young Middle-East affiliate, how Gilead has pivoted to serve evolving healthcare needs during the COVID-19 pandemic,…
Legal & Regulatory
Latest Reports
Morocco Pharma Report 2020
- 2020
Somewhat of a bastion of openness, predictability, and stability in a region often mired with turmoil, volatility, and economic nationalism, Morocco is increasingly attracting the attention of international investors across a range of industries. Nowhere is this more apparent than in the life sciences, where companies are taking note of the country’s strong business fundamentals, solid financial system, international-standard manufacturing, skilled human capital, and reputable legal framework. Though not an enormous domestic pharma market at USD 1.6 billion, Morocco’s position at the crossroads between Europe and Africa is becoming ever more attracting as a base for international firms…
Latest Reports
UAE Pharma Report April 2020
- 2020
The UAE’s pharma market was predicted to grow to USD four billion in 2020, representing a CAGR of 8.5 percent from 2019. The country sits at the heart of the Middle East which, although only making up two percent of the global pharmaceutical industry, has been growing at a rate of ten percent and is therefore increasingly attracting the eye of international investors. With the full fallout of the global coronavirus pandemic still unknown as of April 2020, the UAE nevertheless seems set to remain a highly sought-after investment destination for the foreseeable future. A raft of multinational pharma…
Latest Reports
Egypt Pharma Report July 2019
- 2019
Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations in its region. Nowhere is this trend more apparent than in healthcare. With the launch of the Universal Healthcare Act, which aims to provide health coverage to all of Egypt’s 98 million inhabitants, as well as various national campaigns aimed at eradicating diseases such as Hepatitis C, healthcare and life sciences firms are increasingly cognizant of the abundant opportunities that Egypt has to offer. Topics covered in…
Latest Reports
Turkey Pharma Report 2019
- 2019
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its neighbours – stands as one of the most promising healthcare and life science investment destinations in its region. Topics covered in this report range from the successes of Turkey’s Healthcare Transformation Programme (HTP), which has skyrocketed the level of the country’s healthcare system in little over a decade, the ongoing debate around reimbursement, and a localization policy to which multinational companies are having to adapt. Other hot-button issues touched upon include Turkey’s standing as the world’s…
Latest Reports
Algeria Pharma Report 2019
- 2019
Topics covered in this report – which features the exclusive insights of government ministers, the heads of local pharma champions as well as multinational affiliate leaders – include the potential impact of Algeria's sweeping new healthcare law, the establishment of the country's first National Cancer Plan, global companies’ scramble to localise manufacturing operations, an investment wave from the Middle East, and Algeria’s ramped-up export capabilities.
Latest Reports
Tunisia Pharma Report
- 2017
Transitioning out of a period of instability following the revolution of 2011, Tunisia has much to recommend it within its region. Comparative political stability and a geostrategic location as the northerly most country in Africa are helping turn the Arab world’s only full democracy into an attractive investment destination once again. In terms of healthcare and the life sciences, Tunisia can boast impressive levels of medical tourism; a much-improved market access environment for innovative drugs; a historic and well-established pharmaceutical manufacturing footprint and therefore the potential to export in larger volumes to its neighbors; as well as the…
Latest Reports
Egypt Pharma Report
- 2016
This report offers companies, investors, policymakers, and stakeholders crucial insight into the largest pharmaceutical manufacturing base and the second largest pharmaceuticals market by value in the Middle East. Despite recent political upheaval, Egypt is a key growth market with massive unmet needs and huge potential for potential investors.The report features a foreword from President Abdel Fattah El-Sisi, as well as an in-depth interview with Minister of Health Ahmed Emad El Din Rady. It also includes interview with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors.…
Latest Reports
South Africa Pharma Report
- 2016
This report is an authoritative assessment of the South African healthcare and pharma markets. It features an exclusive in-depth interview with Dr. Aaron Motsoaledi, South African Minister of Health, as well as with leading figures from both public institutions and private companies. Also included are up-to-date facts and figures on South Africa’s healthcare and pharma sectors.
Latest Reports
Mauritius Pharma Report
- 2016
Mauritius is in the process of rebranding itself as a business-friendly, technologically advanced hub for the pharma industry that will act as a bridge between Asia and Africa. This report offers companies, investors, policymakers, and stakeholders crucial insight into this thriving, vibrant country and market. It features an exclusive in-depth interview with the President of Mauritius, Ameenah Gurib-Fakim, as well as interviews with senior executives from the island’s major companies and leaders of its most important institutions. The report also contains updated facts and figures on Mauritius’s healthcare and pharma sectors.
Latest Reports
Turkey Pharma Sector Industry Report
- 2016
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the Turkish pharmaceutical industry; an industry with a rich heritage currently striving to find the balance between fostering domestic growth and building stronger international partnerships. It features interviews with senior executives from the major companies in Turkey and leaders of the country’s most important institutions, updated facts and figures on Turkey’s healthcare and pharma sectors, and an exclusive in-depth cover story, ‘Navigating the Crossroads’.
Focus on Turkey
Boehringer Ingelheim Announces Contract Manufacturing…
Boehringer Ingelheim (BI), the largest private pharma company in the world, has become the latest Big Pharma player to commit to Turkish localization after announcing a contract manufacturing partnership with…
Turkey: A Pharma Talent Hotbed
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has compiled a strategic overview of Turkey’s pharma talent potential, including what local talent can offer…
Read more from Turkey >>
Focus on UAE
The Skills That Regional Pharma Leaders Need in the Middle…
Mohamed Nasser, Amgen’s general manager for the vast Middle East & Africa (MEA) region, leverages his considerable experience managing teams across the region to highlight four skills (and one secret…
The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most of whom seemed more intent on…
Read more from UAE >>
Focus on Saudi Arabia
Saudi Arabia’s Vision 2030 Healthcare Transformation…
Saudi Arabia’s ambitious Vision 2030 economic transformation plan aims at transitioning the Middle East’s largest economy away from an over-reliance on fossil fuels and into a more diversified modern nation.…
Lilly Signs Saudi MoU for Insulin Manufacturing
Saudi Arabia has one of the highest rates of diabetes in the world – over 17 percent of the population are diabetic – making the supply of insulin products a…
Read more from Saudi Arabia >>
Focus on Egypt
Egypt Pharma Update: Trade Deficit Plummets; Big UAE…
As of today, the Evergreen boat that blocked global shipping when it got stuck in the Suez Canal has still not been allowed to leave Egypt. The infamous episode illustrated…
Striking the Access/Innovation Balance in Egyptian…
As Egypt rolls out Universal Health Insurance with the aim of achieving full coverage between 2030 and 2035, the domestic pharmaceutical market stands to see significant long-term shifts. As self-medication…
Read more from Egypt >>
NEW Special Pharma Report on Algeria
Click here to download the Healthcare & Life Sciences Review Algeria 2019 report. Algeria, Africa’s…
Early Access / The UAE as an Initial Product Launch Platform
The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the…
Company Spotlight / Acıbadem's Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
MEA / The Skills That Regional Pharma Leaders Need
Mohamed Nasser, Amgen’s general manager for the vast Middle East & Africa (MEA) region, leverages his…
Download / New UAE Pharma Report April 2020 Out Now
PharmaBoardroom’s latest country report gives an up-to-date and comprehensive overview of one of the most…